Abstract
The effect of methantheline, a quaternary ammonium compound, on the reactivation by HI 6 of soman-inhibted human erythrocyte acetylcholinesterase (AChE) was investigated in vitro using purified human erythrocyte AChE or washed human erythrocytes. Methantheline itself was found to be a mixed competitive/non-competitive inhibitor of AChE (Kii 360±70 μmol/l; Ki 240±10 μmol/l). In all experiments the enzyme was first inhibited by soman for 30 min under conditions preventing ageing (pH 10,0°C) and then ageing was allowed by changing the pH to 7.3 and the temperature to 37°C. Methantheline addition (0.36 or 3.6 mmol/l) at the start of ageing increased the portion of AChE which could be reactivated by HI 6 (0.32 mmol/l) added 5 min later, from 24.6±1.0% (mean±SEM) of the original activity to 42.1±1.8% or 45±2.9%, respectively. With HI 6 alone, the portion of AChE activity which could be reactivated 25 min after the start of ageing decreased rapidly with the delay of the oxime addition (100% of the original activity at immediate addition), the half-life being approximately 2.5 min. With methantheline alone (0.36 mmol/l) the AChE activity was lower after immediate addition (37% of the original value), but the loss of activity due to the increasing delay of methantheline addition exhibited a similar half-life as with HI 6. Finally, when methantheline (0.36 mmol/l) was added at the start of ageing and HI 6 at various intervals thereafter the half-life of AChE activity loss due to the delay of HI 6 addition at least doubled, compared to incubations without methantheline.
Similar content being viewed by others
References
Berman HA, Decker MM (1986) Kinetic, equilibrium, and spectroscopic studies on dealkylation (“ageing”) of alkyl organophosphonyl acetylcholinesterase, J Biol Chem 261: 10646–10652
Berry WK, Davies DR (1966) Factors influencing the rate of “ageing” of a series of alkyl methylphosphonylacetylcholinesterases, Biochem J 100: 572–576
Bisswanger H (1979) Theorie und Methoden der Enzymkinetik. Verlag Chemie, Weinheim
Boskovic B (1981) The treatment of soman poisoning and its perspectives. Fundam Appl Toxicol 1: 203–213
Crone HD (1974) Can allosteric effectors of acetylcholinesterase control the rate of ageing of the phosphorylated enzyme? Biochem Pharmacol 23: 460–463
De Jong LPA, Wolring GZ (1984) Stereospecific reactivation by some Hagedorn-oximes of acetylcholinesterase from various species including man, inhibited by soman. Biochem Pharmacol 38: 1119–1125
Ellman GL, Courtney KD, Andres Jr V, Featherstone RM (1961) A new and rapid clorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88–85
Gugler R (1980) Säuresekretionshemmung durch Cimetidin und Methanthelin. Dtsch Med Wschr 10: 349–350
Hallek M, Szinicz L (1988) Effects of some mono- and bisquaternary ammonium compounds on the reactivatability of soman-inhibited human acetylcholinesterase in vitro. Biochem Pharmacol 37: 819–825
Harris LW, Heyl WC, Stitcher DL, Broomfield CL (1978) Effects of 1,1′-oxydimethylene bis-(4-tert-butyl-pyridinium chloride) (SAD-128) and decamethonium on reactivation of soman- and sarin-inhibited cholinesterase by oximes. Biochem Pharmacol 27: 757–761
Hebjorn S (1977) Treatment of detrusor hyperreflexia in multiple sclerosis. Urol Int 32: 209–217
Hobbiger F (1955) Effect of nicotinhydroxic acid methiodide on human plasma cholinesterase inhibited by organophosphates containing a dialkylphosphato group. Br J Pharmacol 10: 356–362
Lüllmann H, Ohnesorge FK, Tonner HD, Wassermann D, Ziegler A (1971) Influence of alkane-bis-onium compounds upon the activity of the AChE and upon its inhibition by DFP. Biochem Pharmacol 20: 2579–2586
Michel HO, Hackley BE, Berkowitz L, List G, Hackley EB, Gillilan W, Pankau M (1967) Ageing and dealkylation of soman (pinacolylmethylphosphonofluoridate)-inactivated eel cholinesterase. Arch Biochem Biophys 121: 29–34
Nenner M (1970) Gleichzeitige Bestimmung der Aktivität von Acetylcholinesterase in Vollblut, Plasma und Erythrozyten mit dem automatischen Titrator. Z Klin Chem Klin Biochem 8: 537–540
Ohnesorge FK (1969) Effects and mechanisms of action of alkanbisammonium derivatives in organophosphate poisoning. Naunyn-Schmiedeberg’s Arch Pharmacol 263: 27–88
Schoene K (1973) Phosphonyloxime aus Soman: Bildung und Reaktion mit Acetylcholinesterase in vitro. Biochem Pharmacol 22: 2997–3003
Schoene K (1980) Pyridinium salts as organophosphate antagonists. In: Cohen MM (ed) Monogr Neural Sci, vol. 7 Karger, Basel, pp 85–98
Schoene K, Steinhanses J, Oldiges H (1983) Reactivation of soman inhibited acetylcholinesterase in vitro and protection against soman in vivo by bispyridinium-2-aldoximes. Biochem Pharmacol 32: 1649–1651
Scholten T, Fritsch WP, Müller JE, Hengels KJ (1979) Langzeitsuppression der H+-Sekretion durch Kombination von Cimetidin und Methanthelinbromid. Dtsch Med Wschr 104: 1849–1853
Thüroff JW, Frohneberg D, Petri E, Jonas U (1981) Therapie bei Reizblase und Harninkontinenz. Dtsch Med Wschr 106: 215–217
Wilson IB, Alexander J (1962) Acetylcholinesterase inhibitors: reversible inhibitors, substrate inhibition. J Biol Chem 237: 1323–1326
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hallek, M., Szinicz, L. Methantheline improves the reactivation by HI 6 of human erythrocyte acetylcholinesterase inhibited by soman in vitro. Arch Toxicol 70, 16–19 (1995). https://doi.org/10.1007/s002040050243
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002040050243